Search
Search for:
Search for:
Find a Pharmacy
Vertice Login
Menu
About Us
About Us
Our Brand
What We Do
Our People
Contact Us
Careers
FAQ
Workers' Comp Solutions
Workers' Comp Solutions
Pharmacy
Ancillary
Clinical Services
Claims Technology
Claims Technology
Request Demo
Data Analytics
Insights
Insights
RxInformer
Worker's Comprehensive
Clinical Minute
Intelligence
Intelligence
Industry Insights Survey
Industry Insights Survey
2025
2024
2023
2022
2021
2020
2019
Blog
Infographics
Advocacy Compliance
What's Happening
What's Happening
Events
Medmonitor
Social Hub
Customer Center
Customer Center
Pharmacy Search
Ask a Pharmacist
Claims Resources
Claims Resources
Mail Order
Patient Resources
close
Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers
Tag:
COVID-19
88 posts found
Clinical Insights
Biomarkers in the Blood Could Lead to a Long COVID Test
After studying 273 blood samples, researchers could detect long COVID with 96% accuracy.
Read More
COVID-19 Developments
WCRI Publishes Long COVID Report
The likelihood of long COVID, claims costs, and claim duration all increased with the severity of acute COVID-19.
Read More
Clinical Developments
Long COVID Data in Workers’ Comp
Both the WCRI and the New York State Insurance Fund published new reports.
Read More
Industry Trends
COVID-19 Workplace Lessons for Employers
The National Safety Council provides information on mental health, workplace safety, and more.
Read More
COVID-19 Developments
FDA Warns That Certain COVID-19 Variants are Not Neutralized by Evusheld
The only pre-exposure prophylactic for COVID-19 may not provide protection for certain variants.
Read More
COVID-19 Developments
FDA Authorizes Additional Round of COVID-19 Boosters
Moderna and Pfizer boosters have been updated to target the omicron variant.
Read More
Medmonitor
FDA Authorizes New COVID-19 Vaccine
Novavax COVID-19 Vaccine, Adjuvanted will require two doses given three weeks apart.
Read More
COVID-19 Developments
FDA Authorizes Second COVID-19 Booster Dose for Special Populations
Adults aged 50 and older and immunocompromised individuals may receive a second booster dose.
Read More
COVID-19 Developments
FDA Fully Approves Moderna Vaccine & Expands Veklury’s Treatment Range
Drug advancements surrounding the prevention and treatment of COVID-19.
Read More
COVID-19 Developments
Additional Vaccine Candidate Performs Well in Clinical Trials
Phase 3 trials for NVX-CoV2373 across 30,000 people found this vaccine candidate to be safe and effective for the prevention of COVID-19.
Read More
Clinical Insights
CDC Updates Isolation and Quarantine Period for COVID-19
New five-day rules are recommended, with variation depending upon vaccination status.
Read More
Medmonitor
COVID-19 Pill Approval and More Updates
Molnupiravir, Paxlovid, and AZD7442 have shown promise in Phase 3 trials.
Read More
This Month's Must Read
The Long Haul: Chronic Health Complications of COVID-19
Those previously infected by the virus may face long-term health complications.
Read More
Legislation & Policy
Federal Judges Try to Block Vaccine Mandates
Rulings from U.S. District Courts have impeded vaccine requirements among certain workers.
Read More
COVID-19 Developments
FDA Authorizes COVID-19 Booster Shots for All Adults
All adults may now receive a booster shot of any COVID-19 vaccine.
Read More
1
2
3
4
5
6
Next
©
2025
Healthesystems
Workers' Comp Property and Casualty PBM
Expires 01/01/2028
info-circle
caret-right
lock
map-marker
magnifier
cross
menu
arrow-right
cross-circle